Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Cosmo Bio Co stock price, quote, forecast and news

3386.T
JP3298700000

Price

1,088.00
Today +/-
-0.09
Today %
-1.28 %
P

Cosmo Bio Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Cosmo Bio Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Cosmo Bio Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Cosmo Bio Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Cosmo Bio Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Cosmo Bio Co Stock Price History

DateCosmo Bio Co Price
9/11/20241,088.00 undefined
9/10/20241,102.00 undefined
9/9/20241,115.00 undefined
9/6/20241,133.00 undefined
9/5/20241,113.00 undefined
9/4/20241,095.00 undefined
9/3/20241,120.00 undefined
9/2/20241,093.00 undefined
8/30/20241,100.00 undefined
8/29/20241,115.00 undefined
8/28/20241,070.00 undefined
8/27/20241,075.00 undefined
8/26/20241,064.00 undefined
8/23/20241,057.00 undefined
8/22/20241,057.00 undefined
8/21/20241,058.00 undefined
8/20/20241,061.00 undefined
8/19/20241,059.00 undefined
8/16/20241,058.00 undefined
8/15/20241,062.00 undefined

Cosmo Bio Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cosmo Bio Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cosmo Bio Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cosmo Bio Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cosmo Bio Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cosmo Bio Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cosmo Bio Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cosmo Bio Co’s growth potential.

Cosmo Bio Co Revenue, EBIT and net profit per share

DateCosmo Bio Co RevenueCosmo Bio Co EBITCosmo Bio Co Net Income
20239.34 B undefined519 M undefined442 M undefined
20229.55 B undefined816 M undefined517 M undefined
20219.23 B undefined1.05 B undefined737 M undefined
20208.09 B undefined752 M undefined674 M undefined
20197.59 B undefined405 M undefined237 M undefined
20187.26 B undefined328 M undefined260 M undefined
20177.07 B undefined193 M undefined237 M undefined
20167.43 B undefined514 M undefined254 M undefined
20157.36 B undefined200 M undefined230 M undefined
20147.24 B undefined156 M undefined201 M undefined
20137.05 B undefined271 M undefined313 M undefined
20127.24 B undefined774 M undefined411 M undefined
20117.19 B undefined892 M undefined458 M undefined
20106.68 B undefined702 M undefined373 M undefined
20095.28 B undefined457 M undefined137 M undefined
20085.62 B undefined376 M undefined104 M undefined
20075.91 B undefined512 M undefined243.2 M undefined
20065.94 B undefined860.2 M undefined451.3 M undefined
20055.5 B undefined828.1 M undefined553.5 M undefined
20044.97 B undefined750.7 M undefined408.9 M undefined

Cosmo Bio Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
4.814.975.55.945.915.625.286.687.197.247.057.247.367.437.077.267.598.099.239.559.34
-3.3310.627.97-0.51-4.81-6.0526.397.730.68-2.642.621.690.95-4.832.734.536.6114.083.49-2.23
42.0444.8544.5342.4736.9838.2640.9742.6844.2743.9737.1833.5032.3637.3235.8436.6237.9438.9539.6436.0234.80
2.022.232.452.522.182.152.162.853.183.182.622.422.382.772.532.662.883.153.663.443.25
0.560.750.830.860.510.380.460.70.890.770.270.160.20.510.190.330.410.751.050.820.52
11.6015.0915.0614.498.676.698.6510.5212.4010.693.842.162.726.922.734.525.349.2911.358.545.56
299408553451243104137373458411313201230254237260237674737517442
-36.4535.54-18.44-46.12-57.2031.73172.2622.79-10.26-23.84-35.7814.4310.43-6.699.70-8.85184.399.35-29.85-14.51
---------------------
---------------------
5.75.75.26666665.95.95.935.935.935.935.935.935.935.815.815.83
---------------------
Details

Keystats

ⓘ

Revenue and Growth

The Cosmo Bio Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cosmo Bio Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (M)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                         
0.390.791.31.391.321.611.741.592.112.142.041.481.51.951.482.272.523.263.563.043.03
1.051.141.211.961.851.731.632.232.32.312.252.432.392.192.212.272.442.782.712.722.8
528.1504.457999.90443334444400007451
0.350.390.470.50.510.480.450.70.730.840.991.111.141.221.281.010.860.620.861.131.04
32.83884.679.5521038519911111825320723614316399105102182168188
2.352.863.654.033.723.923.914.725.265.415.535.235.275.55.145.655.936.767.317.147.1
31.728.728.942.8615351164179178185213227319690636695636599577572
0.010.121.120.420.890.741.150.760.790.872.222.351.831.591.81.711.821.831.712.152.77
5.75.20000000000000000000
20.221.720.919209910912916515310399224276249252199165182171155
000418.737080616147941100000000
165.4186.3373.9341.4237295275336283329236261240255244243248256271283271
0.230.371.541.241.581.261.641.451.471.542.752.932.522.442.982.842.962.882.763.183.77
2.583.235.195.275.35.195.556.166.736.968.288.167.797.938.138.498.899.6410.0710.3110.87
                                         
286.9317.3898.7913.9918918918918918918918918918918918918918918918918918
0.260.291.21.221.221.221.221.221.221.221.221.221.251.251.251.251.251.251.261.261.26
0.881.261.792.112.22.152.222.522.833.123.313.43.523.683.814.034.184.765.275.565.81
00006-108-44-43-2539899215121189-6171743
0000.2400000836489313341456445551501559513612
1.421.873.894.244.354.184.324.624.945.36.386.126.026.26.456.656.917.438.038.278.64
321.6383.1420507.6513405438397420475566689583462516540565488592573639
23.225.127.713.500000000000000000
315.9482.9431.4294.9201240495412651421232421414434263385402718481445464
157.4106.193.9202020202020202020202020202020202020
0099.3000000000000000000
0.8211.070.840.730.670.950.831.090.920.821.131.020.920.80.950.991.231.091.041.12
99.399.30000000000000000000
0000000000382382494396709878926687
242.1264.7228192.7214341280279296319280318346394393417484475568592636
341.4364228192.7214341280279296319662700395437489487582553660658723
1.161.361.31.030.951.011.231.111.391.241.481.831.411.351.291.431.571.781.751.71.85
2.583.235.195.275.35.195.555.736.336.537.867.957.437.567.748.088.489.29.789.9610.49
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cosmo Bio Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cosmo Bio Co's financial health and stability.

Assets

Cosmo Bio Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cosmo Bio Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cosmo Bio Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cosmo Bio Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20032004200520062007200820092010201120122013201420152016201720182019202020212022
0.560.750.970.810.490.190.440.650.880.770.450.330.410.460.40.40.391.011.10.79
25271917767162787211696847985156178207175166141
00000000000000000000
-379-243-628-677-234-87184-416-155-562-394-54-33622-266455-71-136-560-596
15341-161861283-36-1128218-27-63-219-201-8025-244-57-50
20000000000000000000
291208399483287207454231394652840157170202105143159385279
36157420115739145265420287834612629712957289956549803648285
-29-32-19-24-54-139-53-91-106-106-85-109-199-252-546-152-182-65-141-104
-27-256-1,617-140-70187-382-335-351-167-99-227-26399-235-185-11542-145-291
1-224-1,598-116-16326-329-244-245-61-14-118-64351311-3367107-4-187
00000000000000000000
-170-50-20-99000-20000000000000
00.061.480.030.01000-0.07000-0.0400000-0.190
-0.19-0.021.43-0.18-0.14-0.15-0.07-0.09-0.23-0.13-0.13-0.12-0.15-0.11-0.11-0.09-0.09-0.1-0.42-0.24
---------7.00-8.00-8.00-4.00-3.00-13.00-3.00-3.00-3.00-3.00-3.00-4.00
-17-28-28-112-150-151-66-72-157-118-118-118-106-94-106-82-82-94-223-232
14529814-161179486204-22928961-97-52-285549-26468534874395-218
331.8541.4182.2132.833731360111177224041188-70320-457804367738507181
00000000000000000000

Cosmo Bio Co stock margins

The Cosmo Bio Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cosmo Bio Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cosmo Bio Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cosmo Bio Co's sales revenue. A higher gross margin percentage indicates that the Cosmo Bio Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cosmo Bio Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cosmo Bio Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cosmo Bio Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cosmo Bio Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cosmo Bio Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cosmo Bio Co Margin History

Cosmo Bio Co Gross marginCosmo Bio Co Profit marginCosmo Bio Co EBIT marginCosmo Bio Co Profit margin
202334.8 %5.56 %4.73 %
202236.02 %8.54 %5.41 %
202139.64 %11.35 %7.98 %
202038.95 %9.29 %8.33 %
201937.94 %5.34 %3.12 %
201836.62 %4.52 %3.58 %
201735.84 %2.73 %3.35 %
201637.32 %6.92 %3.42 %
201532.36 %2.72 %3.13 %
201433.5 %2.16 %2.78 %
201337.18 %3.84 %4.44 %
201243.97 %10.69 %5.68 %
201144.27 %12.4 %6.37 %
201042.68 %10.52 %5.59 %
200940.97 %8.65 %2.59 %
200838.26 %6.69 %1.85 %
200736.98 %8.67 %4.12 %
200642.48 %14.49 %7.6 %
200544.52 %15.06 %10.07 %
200444.86 %15.1 %8.23 %

Cosmo Bio Co Stock Sales Revenue, EBIT, Earnings per Share

The Cosmo Bio Co earnings per share therefore indicates how much revenue Cosmo Bio Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cosmo Bio Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cosmo Bio Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cosmo Bio Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cosmo Bio Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cosmo Bio Co Revenue, EBIT and net profit per share

DateCosmo Bio Co Sales per ShareCosmo Bio Co EBIT per shareCosmo Bio Co Earnings per Share
20231,602.48 undefined89.05 undefined75.83 undefined
20221,645.56 undefined140.56 undefined89.06 undefined
20211,589.14 undefined180.42 undefined126.88 undefined
20201,365.05 undefined126.86 undefined113.7 undefined
20191,280.36 undefined68.32 undefined39.98 undefined
20181,224.87 undefined55.33 undefined43.86 undefined
20171,192.31 undefined32.56 undefined39.98 undefined
20161,252.87 undefined86.71 undefined42.85 undefined
20151,241.06 undefined33.74 undefined38.8 undefined
20141,220.48 undefined26.32 undefined33.91 undefined
20131,194.92 undefined45.93 undefined53.05 undefined
20121,227.29 undefined131.19 undefined69.66 undefined
20111,198.67 undefined148.67 undefined76.33 undefined
20101,112.67 undefined117 undefined62.17 undefined
2009880.33 undefined76.17 undefined22.83 undefined
2008937 undefined62.67 undefined17.33 undefined
2007984.33 undefined85.33 undefined40.53 undefined
2006989.45 undefined143.37 undefined75.22 undefined
20051,057.4 undefined159.25 undefined106.44 undefined
2004872 undefined131.7 undefined71.74 undefined

Cosmo Bio Co business model

Cosmo Bio Co is one of the most popular companies on Eulerpool.com.

Cosmo Bio Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Cosmo Bio Co historical P/E ratio, EBIT, and P/S ratio.

Cosmo Bio Co shares outstanding

The number of shares was Cosmo Bio Co in 2023 — This indicates how many shares 5.828 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cosmo Bio Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cosmo Bio Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cosmo Bio Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cosmo Bio Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cosmo Bio Co Stock splits

In Cosmo Bio Co's history, there have been no stock splits.

Cosmo Bio Co dividend history and estimates

In 2023, Cosmo Bio Co paid a dividend amounting to 30 JPY. Dividend means that Cosmo Bio Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Cosmo Bio Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Cosmo Bio Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Cosmo Bio Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Cosmo Bio Co Dividend History

DateCosmo Bio Co Dividend
202330 undefined
202236 undefined
202136 undefined
202034 undefined
201914 undefined
201814 undefined
201714 undefined
201618 undefined
201514 undefined
201420 undefined
201320 undefined
201220 undefined
201120 undefined
201012 undefined
200912 undefined
200811 undefined
200719 undefined
200625 undefined
200515 undefined

Cosmo Bio Co dividend payout ratio

In 2023, Cosmo Bio Co had a payout ratio of 32.9%. The payout ratio indicates the percentage of the company's profits that Cosmo Bio Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Cosmo Bio Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Cosmo Bio Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Cosmo Bio Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Cosmo Bio Co Payout Ratio History

DateCosmo Bio Co Payout ratio
202332.9 %
202240.42 %
202128.37 %
202029.9 %
201935.02 %
201831.92 %
201735.02 %
201642.01 %
201536.08 %
201458.99 %
201337.7 %
201228.71 %
201126.2 %
201019.31 %
200952.56 %
200863.47 %
200746.88 %
200633.24 %
200514.09 %
200432.9 %
Unfortunately, there are currently no price targets and forecasts available for Cosmo Bio Co.

Cosmo Bio Co list of shareholders

%
Name
Stocks
Change
Date
7.43981 % Hikari Tsushin KK435,90003/25/2024
5.07252 % UH Partners 2, Inc.297,20061,8003/25/2024
2.18637 % Cosmo Bio Company Ltd. Employees128,1003,80012/31/2023
19.66200 % Tokyo Small and Medium Business Investment & Consultation Co., Ltd.1,152,000012/31/2023
1.40467 % Suzuki (Yumiko)82,300012/31/2023
1.29715 % Matsunami (Shoichi)76,000012/31/2023
1.28691 % Funato (Toshiaki)75,400012/31/2023
1.17767 % Harada (Masanori)69,000-50012/31/2023
1.05649 % Sakurai (Haruhisa)61,900012/31/2023
1.01724 % Shin Nippon Air Technologies Co Ltd59,60003/31/2023
1
2

Most common questions regarding Cosmo Bio Co

What is the P/E ratio of Cosmo Bio Co 2024?

The P/E ratio cannot be calculated for Cosmo Bio Co at the moment.

What is the P/S ratio of Cosmo Bio Co 2024?

The P/S cannot be calculated for Cosmo Bio Co currently.

What is the AlleAktien quality score of Cosmo Bio Co?

The AlleAktien quality score for Cosmo Bio Co is 3/10.

What is the revenue of Cosmo Bio Co 2024?

The revenue cannot currently be calculated for Cosmo Bio Co.

How high is the profit of Cosmo Bio Co 2024?

The profit cannot currently be calculated for Cosmo Bio Co.

What is the business model of Cosmo Bio Co

No history available for Cosmo Bio Co.

What is the Cosmo Bio Co dividend?

Cosmo Bio Co pays a dividend of 36 JPY distributed over payouts per year.

How often does Cosmo Bio Co pay dividends?

The dividend cannot currently be calculated for Cosmo Bio Co or the company does not pay out a dividend.

What is the Cosmo Bio Co ISIN?

The ISIN of Cosmo Bio Co is JP3298700000.

What is the Cosmo Bio Co ticker?

The ticker of Cosmo Bio Co is 3386.T.

How much dividend does Cosmo Bio Co pay?

Over the past 12 months, Cosmo Bio Co paid a dividend of 30 JPY . This corresponds to a dividend yield of about 2.76 %. For the coming 12 months, Cosmo Bio Co is expected to pay a dividend of 30 JPY.

What is the dividend yield of Cosmo Bio Co?

The current dividend yield of Cosmo Bio Co is 2.76 %.

When does Cosmo Bio Co pay dividends?

Cosmo Bio Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.

How secure is the dividend of Cosmo Bio Co?

Cosmo Bio Co paid dividends every year for the past 19 years.

What is the dividend of Cosmo Bio Co?

For the upcoming 12 months, dividends amounting to 30 JPY are expected. This corresponds to a dividend yield of 2.76 %.

In which sector is Cosmo Bio Co located?

Cosmo Bio Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cosmo Bio Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cosmo Bio Co from 3/1/2025 amounting to 36 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Cosmo Bio Co pay the last dividend?

The last dividend was paid out on 3/1/2025.

What was the dividend of Cosmo Bio Co in the year 2023?

In the year 2023, Cosmo Bio Co distributed 36 JPY as dividends.

In which currency does Cosmo Bio Co pay out the dividend?

The dividends of Cosmo Bio Co are distributed in JPY.

All fundamentals about Cosmo Bio Co

Our stock analysis for Cosmo Bio Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmo Bio Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.